Insulin decreases hepatic acute phase protein levels in severely burned children

Xiaowu Wu1, Steven J Thomas, David N Herndon

  • 1Shriners Hospitals for Children and Department of Surgery, the University of Texas Medical Branch, Galveston, Tex 77550, USA.

Surgery
|January 24, 2004
PubMed

Insights

Continuous insulin treatment significantly reduces acute phase proteins in severely burned children. This suggests insulin helps regulate the body's inflammatory response to severe injury.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Pediatric Critical Care

Background:

  • Severe burns trigger a hepatic acute phase response, characterized by altered protein synthesis.
  • The role of insulin in modulating this response post-burn injury remains incompletely understood.

Purpose of the Study:

  • To investigate the effect of continuous insulin treatment on acute phase protein levels in children with severe burns.
  • To determine if insulin can downregulate the hepatic acute phase response following major trauma.

Main Methods:

  • A randomized controlled trial involving 18 pediatric patients with >40% total body surface area burns.
  • Patients received either continuous insulin infusion to maintain euglycemia or no treatment.
  • Plasma levels of various acute phase and hepatic constitutive proteins were measured at multiple time points post-injury.

Main Results:

  • Insulin treatment led to significant reductions in levels of alpha1-acid glycoprotein, C3 complement, alpha2-macroglobulin, and haptoglobin.
  • These decreases were most pronounced at 21 and 28 days post-burn.
  • Hepatic constitutive proteins (prealbumin, transferrin, retinol-binding protein) were also lower in the insulin group by day 21.

Conclusions:

  • Continuous insulin administration effectively decreases acute phase protein levels in severely burned children.
  • Insulin appears to play a role in downregulating the hepatic acute phase response to severe burn injury.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...